Evolent Health, Inc. Quarterly Interest Expense in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Evolent Health, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2016 to Q1 2024.
  • Evolent Health, Inc. Interest Expense for the quarter ending March 31, 2024 was $6M, a 53.5% decline year-over-year.
  • Evolent Health, Inc. Interest Expense for the twelve months ending March 31, 2024 was $47.3M, a 80.4% increase year-over-year.
  • Evolent Health, Inc. annual Interest Expense for 2023 was $54.2M, a 248% increase from 2022.
  • Evolent Health, Inc. annual Interest Expense for 2022 was $15.6M, a 38.8% decline from 2021.
  • Evolent Health, Inc. annual Interest Expense for 2021 was $25.4M, a 10.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $47.3M $6M -$6.9M -53.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $54.2M $12.2M +$5.81M +90.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $48.4M $14.6M +$9.86M +207% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $38.5M $14.5M +$12.3M +573% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $26.2M $12.9M +$10.7M +475% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $15.6M $6.43M -$18K -0.28% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $15.6M $4.75M -$1.61M -25.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $17.2M $2.15M -$4.13M -65.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $21.3M $2.24M -$4.1M -64.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $25.4M $6.45M -$1.89M -22.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $27.3M $6.37M -$1.05M -14.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $28.4M $6.27M -$16K -0.25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $28.4M $6.34M +$56K +0.89% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $28.3M $8.34M +$4.6M +123% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $23.7M $7.42M +$3.79M +104% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $19.9M $6.29M +$2.67M +73.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $17.3M $6.28M +$2.72M +76.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $14.6M $3.74M +$820K +28.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $13.7M $3.63M +$2.78M +326% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $11M $3.62M +$2.77M +323% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $8.19M $3.56M +$2.71M +318% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q4 2018 $5.48M $2.92M +$2.07M +242% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $3.42M $853K -$27K -3.07% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $3.44M $855K -$92K -9.72% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $3.54M $853K -$101K -10.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $3.64M $855K +$608K +246% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $3.03M $880K +$880K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.15M $947K +$947K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.2M $954K +$954K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $247K $247K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.